London Daily

Focus on the big picture.
Thursday, Oct 09, 2025

Chinese researchers find third Sinovac dose boosts Delta immune response

Chinese researchers find third Sinovac dose boosts Delta immune response

A number of countries are considering boosters or authorising them for certain groups amid the battle against the Delta variant.

A third dose of the Covid-19 vaccine by Sinovac Biotech can boost a flagging immune response to the highly transmissible Delta variant, a team of Chinese researchers has found.

Study participants who received a three-dose regimen of the Sinovac shot showed a more than 2½ times higher neutralising ability against Delta four weeks after the last shot, compared with those who received two doses or had recovered from a naturally acquired Covid-19 infection, according to the small-scale study that has not been peer-reviewed.

The researchers – including scientists from the Chinese Academy of Sciences, Peking University and the vaccine maker – said their data also indicated a third dose would allow vaccine protection to last longer.


The findings “rationalise the use of three-dose immunisation regimens for inactivated vaccines”, they wrote in a paper released on the server medRvix on Sunday.

“Our results demonstrate that a third-dose booster of inactivated vaccine can elicit an expeditious, robust and long-lasting recall humoral [immune] response,” they wrote.

Chinese health officials late last month recommended booster shots for high-risk and vulnerable groups, but said further study was needed before extra jabs were considered for the general public. Five of the seven vaccines in use domestically use an inactivated platform, which relies on a dead version of the virus to stimulate immune response.

Sinovac’s Covid-19 vaccine is among products headlining the domestic roll-out, which has surpassed 2 billion doses. The two-dose vaccine is also widely used around the world.

Limited real-world data has been published on how well the vaccine defends against the Delta variant, which is expected to become dominant worldwide.

Several countries are offering third shots of other vaccines as a boost to Sinovac’s shots following concerns about breakthrough infections as Delta spreads.

But vaccine makers globally have reported diminished protection against the strain, especially against symptomatic disease. A number of countries are considering boosters, or authorising them for certain groups, as concerns loom about the longevity of vaccines and a reduced ability to counter the Delta variant.

The latest study of Sinovac, which relied on lab work not real-world evidence, indicated that four weeks after their final dose the neutralising antibody levels evoked against the Delta variant in people vaccinated with two shots of Sinovac’s vaccine were reduced about 3.7 times compared to that against the original strain.

The researchers also found that six months after vaccination, people who received two doses did not have detectable neutralising activity against the Beta, Gamma and Delta variants, but after the third dose they “exhibited a robust recall” immune response to neutralise variants.

They said their research showed neutralising antibody levels similar to those recorded soon after the second dose were maintained 180 days after the third-dose booster – suggesting the vaccine could last longer with an additional shot.

The study included 22 people who had recovered from Covid-19, six healthy participants and 38 volunteers who received either two or three doses of the vaccine.


The researchers did not discuss what level of protection the vaccine would have against the Delta variant in the real world or the effectiveness against Delta for those six months out from their full vaccination.

Neutralising antibodies are believed to be a key component of the body’s immune defence and an indicator of vaccine effectiveness, but levels typically decline over time.

Another laboratory-based study by a team of British and Indian researchers released on Tuesday found Delta was six times less sensitive to antibodies from individuals who had recovered from a previous infection compared with the earlier dominant strain of the virus.

The variant was also eight times less sensitive to antibodies produced by vaccination with either the Pfizer-BioNTech or AstraZeneca vaccines. The researchers said there was a need to explore “strategies to boost vaccine responses”.

Newsletter

Related Articles

0:00
0:00
Close
France: Less Than a Month After His Appointment, the New French Prime Minister Resigns
Hungarian Prime Minister Viktor Orbán stated that Hungary will not adopt the euro because the European Union is falling apart.
Sarah Mullally Becomes First Woman Appointed Archbishop of Canterbury
Mayor in western Germany in intensive care after stabbing
Australian government pays Deloitte nearly half a million dollars for a report built on fabricated quotes, fake citations, and AI-generated nonsense.
US Prosecutors Gained Legal Approval to Hack Telegram Servers
Macron Faces Intensifying Pressure to Resign or Trigger New Elections Amid France’s Political Turmoil
Standard Chartered Names Roberto Hoornweg as Sole Head of Corporate & Investment Banking
UK Asylum Housing Firm Faces Backlash Over £187 Million Profits and Poor Living Conditions
UK Police Crack Major Gang in Smuggling of up to 40,000 Stolen Phones to China
BYD’s UK Sales Soar Nearly Nine-Fold, Making Britain Its Biggest Market Outside China
Trump Proposes Farm Bailout from Tariff Revenues Amid Backlash from Other Industries
FIFA Accuses Malaysia of Forging Citizenship Documents, Suspends Seven Footballers
Latvia to Bar Tourist and Occasional Buses to Russia and Belarus Until 2026
A Dollar Coin Featuring Trump’s Portrait Expected to Be Issued Next Year
Australia Orders X to Block Murder Videos, Citing Online Safety and Public Exposure
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
×